Historical reconstruction of polychlorinated biphenyl (PCB) exposures for workers in a capacitor manufacturing plant

N. Hopf,A. Ruder,M. Waters

DOI: https://doi.org/10.1007/s11356-013-1590-4

2014-05-01

Environmental Science and Pollution Research International

Abstract:

What problem does this paper attempt to address?

Potential movement of transposable elements through DNA circularization

T. Mourier

DOI: https://doi.org/10.1007/s00294-016-0592-4

2016-03-15

Current Genetics

Abstract:
Trends of Diabetic Retinopathy Research from 2018-2022: A bibliometric analysis

Ariadne Aulia

DOI: https://doi.org/10.35749/0pkq8308

2024-02-12

Ophthalmologica Indonesiana

Abstract:Introduction & Objectives : Diabetic Retinopathy (DR) is one of the leading cause of visual impairment and blindness. Abundant studies have been done around the topic. This study aims to identify research hotspot of DR during the last five years. Methods : Document search in the Scopus database was done using the term “diabetic retinopathy” in Title, Abstracts, and Author Keywords. We included only articles written in English published between 2018 and 2022. The dataset were analyzed using VOSviewer to conduct bibliometric analysis, such as citation analysis of sources and institutions, co-authorship analysis of countries, and co- occurrence analysis of author keywords. Results : A total of 8.377 articles on DR were retrieved. Number of articles in DR had been increasing steadily overtime. China had the most publications with over 2.000 articles, while United States had the most international collaboration. The most active institution was Guangdong Provincial Clinical Research Center for Ocular Diseases. Scientific Reports was the most prolific journal in DR research. Co- occurrence analysis of author keywords formed 5 clusters; DR management, risk factors for DR, examination for DR, pathogenesis of DR, and diagnostic method for DR. Conclusion : This study revealed research trends on diabetic retinopathy research for the last five years. It may provide information for researchers to identify potential collaborator and give better insight on DR research topics
NEW NUMERICAL APPROXIMATIONS FOR SPACE-TIME FRACTIONAL BURGERS' EQUATIONS VIA A LEGENDRE SPECTRAL-COLLOCATION METHOD

A. Bhrawy,M. Zaky,D. Baleanu,S. Arabia

Abstract:This paper reports a new space-time spectral algorithm for obtaining an approximate solution for the space-time fractional Burger’s equation (FBE) based on spectral shifted Legendre collocation (SLC) method in combination with the shifted Lagendre operational matrix of fractional derivatives. The fractional derivatives are described in the Caputo sense. We propose a spectral shifted Legendre collocation method in both temporal and spatial discretizations for the space-time FBE. The main characteristic behind this approach is that it reduces such problem to those of solving a system of nonlinear algebraic equations which can then be solved using Newtons iterative method. Numerical results with comparisons are given to confirm the reliability of the proposed method for FBE
Trends in prevalence rates of blindness among patients with diabetic retinopathy in high-income countries from 1990 to 2019: A joinpoint regression analysis

Jianqi Chen,Yingting Zhu,Zhidong Li,Yuan Zhang,Guitong Ye,Kezhe Chen,Xiaohua Zhuo,Shaochong Zhang,Lifeng Lin,Yehong Zhuo

DOI: https://doi.org/10.1016/j.diabres.2023.110823

IF: 8.18

2023-07-09

Diabetes Research and Clinical Practice

Abstract:Aims Diabetic retinopathy (DR) is the leading cause of blindness in patients with diabetes mellitus (DM). We investigated its trends in high-income countries to gain insights into preventing DR-related blindness in diabetes-epidemic areas. Methods For joinpoint regression analysis, we extracted data from the Global Burden of Disease 2019 study and analysed the prevalence trends of DR-related blindness according to DM type, patients' sex and age, region, and nation. Results Overall, the age-standardised prevalence rate (ASPR) of DR-related blindness has decreased. The prevalence rates of blindness decreased more sharply for Type 1 DM than for Type 2 DM. The ASPR was higher and the decreasing trend was less pronounced in women than in men. Southern Latin America had the highest ASPR, whereas Australasia had the lowest ASPR. Singapore experienced the greatest decline, whereas unfavourable trends were observed in the USA. Conclusions Despite decrease in the overall ASPR of DR-related blindness during the study period, large improvement opportunities were identified. As DM prevalence increases and the population ages rapidly in high-income countries, novel effective screening, treatment, and prevention strategies are urgently needed to improve the visual outcomes of individuals with DM or at risk of DM.

endocrinology & metabolism
Global research trends and future directions in diabetic macular edema research: A bibliometric and visualized analysis

Yuanyuan Li,Chuanhong Jie,Jianwei Wang,Weiqiong Zhang,Jingying Wang,Yu Deng,Ziqiang Liu,Xiaoyu Hou,Xuqi Bi

DOI: https://doi.org/10.1097/md.0000000000038596

IF: 1.6

2024-06-23

Medicine

Abstract:Diabetic macular edema (DME) represents a critical public health issue due to its role in visual impairment among patients with diabetes. [ 1–3 ] Research indicates that over two-thirds of patients with real-world DME experience a visual acuity of less than 0.5, significantly affecting their visual health. [ 4 , 5 ] Although significant strides have been made in understanding DME's epidemiology, pathophysiology, and treatment options, discrepancies and gaps in current research persist. For instance, while the effectiveness of anti-Vascular Endothelial Growth Factor (anti-VEGF) treatments is well-documented, responses vary among individuals, highlighting the need for alternative strategies and a deeper understanding of disease mechanisms. This study aims to provide a comprehensive bibliometric analysis, encompassing the extensive scope of DME research to elucidate trends, identify significant contributions, and outline evolving frontiers within this field.

medicine, general & internal
Global Prevalence and Major Risk Factors of Diabetic Retinopathy

Joanne W.Y. Yau,Sophie L. Rogers,Ryo Kawasaki,Ecosse L. Lamoureux,Jonathan W. Kowalski,Toke Bek,Shih-Jen Chen,Jacqueline M. Dekker,Astrid Fletcher,Jakob Grauslund,Steven Haffner,Richard F. Hamman,M. Kamran Ikram,Takamasa Kayama,Barbara E.K. Klein,Ronald Klein,Sannapaneni Krishnaiah,Korapat Mayurasakorn,Joseph P. O’Hare,Trevor J. Orchard,Massimo Porta,Mohan Rema,Monique S. Roy,Tarun Sharma,Jonathan Shaw,Hugh Taylor,James M. Tielsch,Rohit Varma,Jie Jin Wang,Ningli Wang,Sheila West,Liang Xu,Miho Yasuda,Xinzhi Zhang,Paul Mitchell,Tien Y. Wong,,

DOI: https://doi.org/10.2337/dc11-1909

2012-02-10

Diabetes Care

Abstract:OBJECTIVE To examine the global prevalence and major risk factors for diabetic retinopathy (DR) and vision-threatening diabetic retinopathy (VTDR) among people with diabetes. RESEARCH DESIGN AND METHODS A pooled analysis using individual participant data from population-based studies around the world was performed. A systematic literature review was conducted to identify all population-based studies in general populations or individuals with diabetes who had ascertained DR from retinal photographs. Studies provided data for DR end points, including any DR, proliferative DR, diabetic macular edema, and VTDR, and also major systemic risk factors. Pooled prevalence estimates were directly age-standardized to the 2010 World Diabetes Population aged 20–79 years. RESULTS A total of 35 studies (1980–2008) provided data from 22,896 individuals with diabetes. The overall prevalence was 34.6% (95% CI 34.5–34.8) for any DR, 6.96% (6.87–7.04) for proliferative DR, 6.81% (6.74–6.89) for diabetic macular edema, and 10.2% (10.1–10.3) for VTDR. All DR prevalence end points increased with diabetes duration, hemoglobin A1c, and blood pressure levels and were higher in people with type 1 compared with type 2 diabetes. CONCLUSIONS There are approximately 93 million people with DR, 17 million with proliferative DR, 21 million with diabetic macular edema, and 28 million with VTDR worldwide. Longer diabetes duration and poorer glycemic and blood pressure control are strongly associated with DR. These data highlight the substantial worldwide public health burden of DR and the importance of modifiable risk factors in its occurrence. This study is limited by data pooled from studies at different time points, with different methodologies and population characteristics.

endocrinology & metabolism
Diabetic retinopathy in China: Epidemiology, screening and treatment trends—A review

Xiaorong Li,Tien‐En Tan,Tien Y. Wong,Xiaodong Sun

DOI: https://doi.org/10.1111/ceo.14269

2023-06-29

Abstract:Diabetic retinopathy (DR) is the leading cause of vision impairment in the global working‐age population. In China, with one‐third of the world's diabetes population estimated at 141 million, the blindness prevalence due to DR has increased significantly. The country's geographic variations in socioeconomic status have led to prominent disparities in DR prevalence, screening and management. Reported risk factors for DR in China include the classic ones, such as long diabetes duration, hyperglycaemia, hypertension and rural habitats. There is no national‐level DR screening programme in China, but significant pilot efforts are underway for screening innovations. Novel agents with longer durations, noninvasive delivery or multi‐target are undergoing clinical trials in China. Although optimised medical insurance policies have enhanced accessibility for expensive therapies like anti‐VEGF drugs, further efforts in DR prevention and management in China are required to establish nationwide cost‐effective screening programmes, including telemedicine and AI‐based solutions, and to improve insurance coverage for related out‐of‐pocket expenses.

ophthalmology
The natural history of hepatitis-associated (Australia)-antigen (HAA)-positive chronic liver disease.

F. Dudley,P. Scheuer,S. Sherlock

IF: 24.5

1972-10-01

Gut

Abstract:
The progress in understanding and treatment of diabetic retinopathy

Alan W. Stitt,Timothy M. Curtis,Mei Chen,Reinhold J. Medina,Gareth J. McKay,Alicia Jenkins,Thomas A. Gardiner,Timothy J. Lyons,Hans-Peter Hammes,Rafael Simó,Noemi Lois

DOI: https://doi.org/10.1016/j.preteyeres.2015.08.001

IF: 19.704

2016-03-01

Progress in Retinal and Eye Research

Abstract:Diabetic retinopathy is the most frequently occurring complication of diabetes mellitus and remains a leading cause of vision loss globally. Its aetiology and pathology have been extensively studied for half a century, yet there are disappointingly few therapeutic options. Although some new treatments have been introduced for diabetic macular oedema (DMO) (e.g. intravitreal vascular endothelial growth factor inhibitors ('anti-VEGFs') and new steroids), up to 50% of patients fail to respond. Furthermore, for people with proliferative diabetic retinopathy (PDR), laser photocoagulation remains a mainstay therapy, even though it is an inherently destructive procedure. This review summarises the clinical features of diabetic retinopathy and its risk factors. It describes details of retinal pathology and how advances in our understanding of pathogenesis have led to identification of new therapeutic targets. We emphasise that although there have been significant advances, there is still a pressing need for a better understanding basic mechanisms enable development of reliable and robust means to identify patients at highest risk, and to intervene effectively before vision loss occurs.

ophthalmology
Emerging drugs for the treatment of diabetic retinopathy

Elio Striglia,Andrea Caccioppo,Niccolò Castellino,Michele Reibaldi,Massimo Porta

DOI: https://doi.org/10.1080/14728214.2020.1801631

2020-07-02

Expert Opinion on Emerging Drugs

Abstract:Diabetic retinopathy (DR) is one of the main pathological features of the diabetes mellitus spectrum. It is estimated that in 2020 about 4 million people worldwide suffered from blindness or visual impairment caused by DR. Many patients cannot access treatment, mostly because of high costs, while others discontinue it prematurely due to the high number of intravitreal administrations required, or the occurrence of ocular complications, or discomfort in quality of life.The aims of this paper are to summarize the current understanding of the pathogenesis and treatment of diabetic retinopathy, focus on the most promising new approaches to treatment that are being evaluated in clinical trials, and outline the potential financial impact of new drugs in future markets.Slow-release systems with steroids, anti-VEGF or sunitinib are promising. Oral imatinib would avoid the ocular complications of intravitreal drugs. Brolucizumab and abicipar pegol may be superior to aflibercept and ranibizumab with the advantage of less frequent administrations. Faricimab, active on Tie-2 receptors, is being evaluated in two phase 3 clinical trials. Further knowledge of the efficacy and safety of these drugs is necessary before their final approval for the treatment of diabetic retinopathy.

pharmacology & pharmacy
Current research and future strategies for the management of vision-threatening diabetic retinopathy

Huating Li,Weiping Jia,Stela Vujosevic,Charumathi Sabanayagam,Jakob Grauslund,Sobha Sivaprasad,Tien Yin Wong

DOI: https://doi.org/10.1016/j.apjo.2024.100109

Abstract:Diabetic retinopathy (DR) is a major ocular complication of diabetes and the leading cause of blindness and visual impairment, particularly among adults of working-age adults. Although the medical and economic burden of DR is significant and its global prevalence is expected to increase, particularly in low- and middle-income countries, a large portion of vision loss caused by DR remains preventable through early detection and timely intervention. This perspective reviewed the latest developments in research and innovation in three areas, first novel biomarkers (including advanced imaging modalities, serum biomarkers, and artificial intelligence technology) to predict the incidence and progression of DR, second, screening and early detection of referable DR and vision-threatening DR (VTDR), and finally, novel therapeutic strategies for VTDR, including diabetic macular oedema (DME), with the goal of reducing diabetic blindness.
Uniformity of serotype and electropherotype in local human rotavirus isolates during each of three successive cold seasons.

I. Shif,I. Silberstein,Y. Aboudy,E. Mendelson,A. Mates,T. Gotlieb‐Stematsky

DOI: https://doi.org/10.1093/IJE/21.2.399

IF: 9.685

1992-04-01

International Journal of Epidemiology

Abstract:Each of three consecutive cold seasons (November-March) in the town of Tiberias, Israel, was dominated by one particular rotavirus serotype causing acute diarrhoea in the community: the 1987/88 season by serotype-2; 1988/89 by serotype-1 and 1989/90 by serotype-4. Each season was also characterized by a particular pattern of rotaviral RNA when visualized using electrophoresis in gels. RNA profiles of identical rota serotypes and serotypic prevalence for any given cold season were unique for the town of Tiberias and different from other localities throughout Israel. The meaning of these findings in terms of herd immunity is discussed.
Bibliometric and visualized analysis of DME from 2012 to 2022

Yi Liu,Qiuyan Zhu,Pengfei Jiang,Yang Yang,Mingyun Wang,Hao Liang,Qinghua Peng,Qiuyan Zhang

DOI: https://doi.org/10.1097/md.0000000000037347

IF: 1.6

2024-03-30

Medicine

Abstract:Background: Diabetic macular edema (DME) is the main cause of irreversible vision loss in patients with diabetes mellitus (DM), resulting in a certain burden to patients and society. With the increasing incidence of DME, more and more researchers are focusing on it. Methods: The papers related to DME between 2012 and 2022 from the Web of Science core Collection were searched in this study. Based on CiteSpace and VOS viewer, these publications were analyzed in terms of spatiotemporal distribution, author distribution, subject classification, topic distribution, and citations. Results: A total of 5165 publications on DME were included. The results showed that the research on DME is on a steady growth trend. The country with the highest number of published documents was the US. Wong Tien Yin from Tsinghua University was the author with the most published articles. The journal of Retina, the Journal of Retinal and Vitreous Diseases had a large number of publications. The article "Mechanisms of macular edema: Beyond the surface" was the highly cited literature and "Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema" had the highest co-citation frequency. The treatment, diagnosis, pathogenesis, as well as etiology and epidemiological investigation of DME, have been the current research direction. Deep learning has been widely used in the medical field for its strong feature representation ability. Conclusions: The study revealed the important authoritative literature, journals, institutions, scholars, countries, research hotspots, and development trends in in the field of DME. This indicates that communication and cooperation between disciplines, universities, and countries are crucial. It can advance research in DME and even ophthalmology.

medicine, general & internal
Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema

Jie Ding,Tien Yin Wong

DOI: https://doi.org/10.1007/s11892-012-0283-6

2012-05-15

Current Diabetes Reports

Abstract:With increasing global prevalence of diabetes, diabetic retinopathy (DR) is set to be the principle cause of vision impairment in many countries. DR affects a third of people with diabetes and the prevalence increases with duration of diabetes, hyperglycemia, and hypertension—the major risk factors for the onset and progression of DR. There are now increasing data on the epidemiology of diabetic macular edema (DME), an advanced complication of DR, with studies suggesting DME may affect up to 7 % of people with diabetes. The risk factors for DME are largely similar to DR, but dyslipidemia appears to play a more significant role. Early detection of DR and DME through screening programs and appropriate referral for therapy is important to preserve vision in individuals with diabetes. Future research is necessary to better understand the potential role of other risk factors such as apolipoproteins and genetic predisposition to shape public health programs.

endocrinology & metabolism
Status and Trends of the Association Between Diabetic Nephropathy and Diabetic Retinopathy From 2000 to 2021: Bibliometric and Visual Analysis

Wenwen Lin,Yayong Luo,Fang Liu,Hangtian Li,Qian Wang,Zheyi Dong,Xiangmei Chen

DOI: https://doi.org/10.3389/fphar.2022.937759

2022-06-20

Abstract:Background: Diabetic nephropathy (DN) and diabetic retinopathy (DR) are microvascular complications of diabetes that share a similar pathogenesis and clinical relevance. The study aimed to visually analyze the research status and development trend of the relationship between DN and DR by means of bibliometrics and knowledge mapping. Methods: Publications were collected from the Science Citation Index-Expanded of the Web of Science Core Collection between 2000 and 2021. CiteSpace, Alluvial Generator, and Microsoft Excel were used to analyze and present the data. Results: A total of 3,348 publications were retrieved and 3,285 were included in the analysis after deduplication. The publications demonstrated an annually increasing trend. The results of the collaborative network analysis showed that the United States, Steno Diabetes Center, and Tien Y. Wong were the most influential country, institution and author, in this field of research, respectively. The analysis of references and keywords showed that the pathogenesis of DN and DR and their relationship with cardiovascular disease are research hotspots. The clinical relevance and drug therapy for DN and DR will become frontiers of future research in this field. Conclusion: This study is the first to visualize the correlation between DN and DR using a bibliometric approach. This study provides a reference of research trends for scholars.
Recent Progression of Pathogenesis and Treatment for Diabetic Cataracts

Yike Li,An-Peng Pan,A-Yong Yu

DOI: https://doi.org/10.1080/08820538.2024.2427789

2024-11-17

Seminars in Ophthalmology

Abstract:Background: Cataracts are still the main cause of blindness worldwide. The incidence of cataracts in the diabetic population is 3-5 times higher than in healthy people. With the increasing incidence of diabetes and the development of aging, as well as the higher risk of surgical and postoperative complications of diabetic patients undergoing surgery, it is still necessary to study the occurrence and development mechanism of diabetic cataracts as well as potential therapeutic targets and therapeutic drugs. Methods: A retrospective review of the literature from PubMed (2017-2024). Results: We summarized the the current literature on the molecular mechanism and prevention and treatment of diabetic cataracts. Conclusions: The aqueous humor metabolism changes, oxidative stress, reactive oxygen species generation increase, the conversion of polyol pathway, as well as non-coding RNA expression changes play important roles in diabetic cataract and these processes is closely linked with each other. Inhibitors or drugs target to these processes, such as aldose reductase inhibitors, antioxidants, natural flavonoid compounds, as well as nanotechnology-based therapeutic product, have shown promising prospects in the prevention and treatment of diabetic cataract.

ophthalmology
Global hotspots and trends in diabetic peripheral neuropathy research from 2011 to 2023

Fei Tang,Fukun Zhao,Yong Jiang,Tao Zhang,Bangfeng Wang

DOI: https://doi.org/10.1097/MD.0000000000039295

2024-08-09

Abstract:Diabetic peripheral neuropathy (DPN) is a prevalent disease, and the relevant literature has been increasingly investigated over the past years. Consequently, it is imperative to conduct a scientific and comprehensive DPN research field bibliometric analysis. This study aims to summarize and visualize the literature distribution laws, the research hotspots, and the development trends in DPN using bibliometric methods. We searched all relevant documents published from 2011 to 2023 in the Web of Science Core Collection. Bibliometric analysis and network visualization were performed using VOSviewer, R-bibliometrix, and CiteSpace tools, focusing on countries, institutions, authors, journals, highly cited papers, references, and keywords. This study included a total of 2708 documents. The annual number of publications in the field has notably increased. China, the USA, and the UK take on critical significance in DPN research. The University of Manchester in the UK has the highest number of publications (109). Malik has the most publications (86). Tesfaye literature has been most frequently cited by scholars of DPN research. The Journal of Diabetes and its Complications and Frontiers in Endocrinology have the most publications (45 each). Diabetes Care stands out with the highest impact factor (16.200), number of citations (2516), and H-index (27) among the number of publications top 10 journals. The paper "Colloca, L. et al Neuropathic pain. Nature Reviews Disease Primers. 2017, 3 (1):1-19" has the highest number of citations (1224 times). The most critical co-cited reference is "Tesfaye S, 2010, DIABETES CARE, V33, P2285" (cited 408 times). Keywords like "type 2 diabetes," "diagnosis," "association," "retinopathy," "risk factors," "progression," "corneal confocal microscopy," "nephropathy," "balance," "microvascular complications," "inflammation," "disease," and "insulin resistance" represent the recent research hotspots. The development, research hotspots, and future trends of the global DPN domain from 2011 to 2023 were summarized and visualized in this study. This study can present more insights into the general situation of DPN research and provide a useful reference for clinical decision-making and directions of subsequent research.
493 DECREASING PERINATAL MORTALITY IN A LARGE URBAN CENTER

W. Rosenfeld,R. Jhaveri,D. Salazar,R. Estrada,H. Evans

DOI: https://doi.org/10.1203/00006450-198104001-00506

IF: 3.953

1981-04-01

Pediatric Research

Abstract:From 1974-79, JHMCB, located in Bedford-Stuyvesant, an inner city community, has experienced a significant decrease in perinatal mortality reflecting improvement in both fetal and neonatal outcome. During the 6yrs, the proportion of high risk obstetrical patients has increased while the proportion of low b.wt. patients remained stable. Improved mortality has been associated with a decreased proportion of forceps deliveries (low & mid) and inductions of labor. Improvements in the monitoring program, structural changes in the NICU, and increased staffing of the obstetrical unit and NICU also coincided with decreased mortality. The proportion of births, and of breech presentations, delivered by Cesearean section and the effects of the abortion program did not appear to influence mortality rates.The decrease in neonatal mortality to levels below national averages was reflected by improvement of outcome in patients over a range of 751-2500gms. No improvement occurred in those with birth weight of less than 750gms.These results suggest that the influence of adverse socioeconomic circumstances can be overcome and improved perinatal mortality is possible.
[PET/CT for colorectal and hepatic tumors].

J. Stollfuss,H. Wieder,E. Rummeny,M. Schwaiger

DOI: https://doi.org/10.1007/S00117-004-1123-8

2004-11-01

Der Radiologe

Abstract:
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis.

Zhen Ling Teo,Yih-Chung Tham,Marco Yu,Miao Li Chee,Tyler Hyungtaek Rim,Ning Cheung,Mukharram M Bikbov,Ya Xing Wang,Yating Tang,Yi Lu,Ian Y Wong,Daniel Shu Wei Ting,Gavin Siew Wei Tan,Jost B Jonas,Charumathi Sabanayagam,Tien Yin Wong,Ching-Yu Cheng

DOI: https://doi.org/10.1016/j.ophtha.2021.04.027

IF: 14.277

2021-01-01

Ophthalmology

Abstract:TOPIC:To provide updated estimates on the global prevalence and number of people with diabetic retinopathy (DR) through 2045. CLINICAL RELEVANCE:The International Diabetes Federation (IDF) estimated the global population with diabetes mellitus (DM) to be 463 million in 2019 and 700 million in 2045. Diabetic retinopathy remains a common complication of DM and a leading cause of preventable blindness in the adult working population. METHODS:We conducted a systematic review using PubMed, Medline, Web of Science, and Scopus for population-based studies published up to March 2020. Random effect meta-analysis with logit transformation was performed to estimate global and regional prevalence of DR, vision-threatening DR (VTDR), and clinically significant macular edema (CSME). Projections of DR, VTDR, and CSME burden were based on population data from the IDF Atlas 2019. RESULTS:We included 59 population-based studies. Among individuals with diabetes, global prevalence was 22.27% (95% confidence interval [CI], 19.73%-25.03%) for DR, 6.17% (95% CI, 5.43%-6.98%) for VTDR, and 4.07% (95% CI, 3.42%-4.82%) for CSME. In 2020, the number of adults worldwide with DR, VTDR, and CSME was estimated to be 103.12 million, 28.54 million, and 18.83 million, respectively; by 2045, the numbers are projected to increase to 160.50 million, 44.82 million, and 28.61 million, respectively. Diabetic retinopathy prevalence was highest in Africa (35.90%) and North American and the Caribbean (33.30%) and was lowest in South and Central America (13.37%). In meta-regression models adjusting for habitation type, response rate, study year, and DR diagnostic method, Hispanics (odds ratio [OR], 2.92; 95% CI, 1.22-6.98) and Middle Easterners (OR, 2.44; 95% CI, 1.51-3.94) with diabetes were more likely to have DR compared with Asians. DISCUSSION:The global DR burden is expected to remain high through 2045, disproportionately affecting countries in the Middle East and North Africa and the Western Pacific. These updated estimates may guide DR screening, treatment, and public health care strategies.

Historical reconstruction of polychlorinated biphenyl (PCB) exposures for workers in a capacitor manufacturing plant

Potential movement of transposable elements through DNA circularization

Trends of Diabetic Retinopathy Research from 2018-2022: A bibliometric analysis

NEW NUMERICAL APPROXIMATIONS FOR SPACE-TIME FRACTIONAL BURGERS' EQUATIONS VIA A LEGENDRE SPECTRAL-COLLOCATION METHOD

Trends in prevalence rates of blindness among patients with diabetic retinopathy in high-income countries from 1990 to 2019: A joinpoint regression analysis

Global research trends and future directions in diabetic macular edema research: A bibliometric and visualized analysis

Global Prevalence and Major Risk Factors of Diabetic Retinopathy

Diabetic retinopathy in China: Epidemiology, screening and treatment trends—A review

The natural history of hepatitis-associated (Australia)-antigen (HAA)-positive chronic liver disease.

The progress in understanding and treatment of diabetic retinopathy

Emerging drugs for the treatment of diabetic retinopathy

Current research and future strategies for the management of vision-threatening diabetic retinopathy

Uniformity of serotype and electropherotype in local human rotavirus isolates during each of three successive cold seasons.

Bibliometric and visualized analysis of DME from 2012 to 2022

Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema

Status and Trends of the Association Between Diabetic Nephropathy and Diabetic Retinopathy From 2000 to 2021: Bibliometric and Visual Analysis

Recent Progression of Pathogenesis and Treatment for Diabetic Cataracts

Global hotspots and trends in diabetic peripheral neuropathy research from 2011 to 2023

493 DECREASING PERINATAL MORTALITY IN A LARGE URBAN CENTER

[PET/CT for colorectal and hepatic tumors].

Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis.